Opdivo (nivolumab) - Ono Pharmaceutical, BMS
bleomycin - Generic mfg.
Adcetris (brentuximab vedotin) - Takeda, Pfizer
Duality of Rarity of Chemotherapy-induced Flagellate Erythema among Cancer Patients: A Case Report with 26 Years of Evidence in Oncology. (PubMed, Curr Drug Saf) - Oct 1, 2026 - "Healthcare professionals should be aware of and vigilant for this whip-like dermatological manifestation (FD) when choosing Bleomycin-based therapy. A patient-centric approach to cessation or rechallenge with the culprit drug, along with antihistamines and topical/ oral corticosteroids, is the mainstay for the management of FD." 
Journal • Cough • Dermatitis • Dermatology • Hematological Malignancies • Hodgkin Lymphoma • Immunology • Lymphoma • Oncology • Respiratory Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42813625
 
Anusha Hegde; Rajesh Krishna; Rajesh Raju; Raushan Kumar Chaudhary; Revathy Nandakumar
 
Oct 1, 2026
 
Prev Next